Keyphrases
AAAS Gene
33%
Arterial Spin Labeling
11%
Bilateral Optic Neuritis
33%
Brain Magnetic Resonance Imaging
19%
Clinically Meaningful Improvement
11%
Collapsin Response Mediator Protein
33%
Congenital Myasthenic Syndrome
33%
Decarboxylase
11%
Diffusion Tensor Imaging DTI
11%
Dopa Decarboxylase
11%
Dopamine Transporter
11%
Dopaminergic Neurons
11%
Durvalumab
33%
Esophageal Achalasia
16%
Genetic Testing
16%
Hand Function
11%
Immune Checkpoint Inhibitors
22%
Lower Extremity
16%
Lung Cancer
33%
Magnetic Resonance Imaging
17%
Minimal Clinically Important Difference
11%
Monoamine Oxidase B (MAO-B)
11%
Movement Disorder Society
11%
Multiple Sclerosis
16%
Myelin Oligodendrocyte Glycoprotein Antibody
33%
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)
33%
Neurological Effects
33%
Neuromelanin
66%
Neuromelanin-sensitive MRI
33%
Neuromyelitis Optica Spectrum Disorder (NMOSD)
25%
Older Men
17%
Paraneoplastic Cerebellar Degeneration
33%
Paraneoplastic Syndrome
33%
Parkinson Patients
66%
Parkinson's Disease
22%
PFC Prefrontal Cortex
11%
Polar Areas
44%
Randomized Crossover Trial
33%
Repetitive Transcranial Magnetic Stimulation (rTMS)
11%
Simple Test
11%
Single-photon Emission Computed Tomography (SPECT)
22%
Small Cell Lung Cancer
17%
SNpc
11%
Steroid Pulse Therapy
14%
Substantia Nigra
66%
Substantia Nigra Pars Compacta
11%
Timed Up-and-go Test
11%
Transcranial Direct-current Stimulation (tDCS)
66%
Triple A Syndrome
33%
Tumefactive Demyelinating Lesion
33%
Medicine and Dentistry
(3 Iodobenzyl)guanidine
8%
Achalasia
16%
Adrenal Insufficiency
8%
Adverse Event
33%
Allgrove Syndrome
33%
Arterial Spin Labeling
8%
Ataxia
11%
Blood Examination
11%
Chorea
11%
Collapsin Response Mediator Protein
33%
Decarboxylase Inhibitor
8%
Diffusion Tensor Imaging
8%
Disease
22%
Durvalumab
33%
Electrical Brain Stimulation
8%
Gadolinium
11%
Genetic Screening
16%
Hand Function
8%
Headache
11%
Immune Checkpoint Inhibitor
22%
Lung Cancer
33%
Magnetic Resonance Imaging
45%
Minimal Clinically Important Difference
8%
Multiple Sclerosis
33%
Muscle Weakness
13%
Myelin Oligodendrocyte Glycoprotein
22%
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
33%
Myelodysplastic Syndrome
8%
Neurologic Disease
11%
Neuromelanin
66%
Neuromuscular Junction Disorder
33%
Occipital Lobe
11%
Optic Nerve
11%
Optic Neuritis
33%
Orthostatic Hypotension
8%
Paraneoplastic Cerebellar Degeneration
66%
Parkinson's Disease
66%
Plasma Exchange
11%
Prednisolone
11%
Pulse Rate
17%
Repetitive Transcranial Magnetic Stimulation
8%
Sensation
8%
Single-Photon Emission Computed Tomography
16%
Small Cell Lung Cancer
17%
Spectrum Disorder
33%
Stereotypic Movement Disorder
16%
Steroid Therapy
11%
Substantia nigra
66%
Transcranial Direct Current Stimulation
66%
Visual Impairment
11%
Neuroscience
Adenosine Triphosphate
33%
Aromatic L-Amino Acid Decarboxylase Inhibitor
8%
Arterial Spin Labeling
8%
Ataxia
33%
Blood Plasma
8%
Carboxy-Lyases
8%
Cisplatin
33%
Computed Tomography
33%
Diffusion Tensor Imaging
8%
Dopamine Transporter
8%
Dopaminergic Neuron
8%
Dysarthria
33%
Electrical Brain Stimulation
8%
Etoposide
33%
Functional Connectivity
9%
Headache
8%
Immunotherapy
35%
Intravenous Immunoglobulin
33%
Iobenguane
8%
Iodine-123
8%
Locus Coeruleus
8%
Magnetic Resonance Imaging
50%
Magnetic Resonance Imaging
8%
Monoamine Oxidase B
8%
Multiple Sclerosis
58%
Myelin Oligodendrocyte Glycoprotein
33%
Nervous System Disorder
12%
Neuromelanin
66%
Neuromyelitis Optica
33%
Occipital Lobe
8%
Optic Nerve
8%
Optic Neuritis
33%
Parkinson's Disease
66%
Polyneuropathy
33%
Prednisolone
8%
Prefrontal Cortex
8%
Primary Motor Cortex
8%
Single-Photon Emission Computed Tomography
16%
Spectrum Disorder
25%
Stereotypic Movement Disorder
16%
Substantia nigra
66%
Substantia Nigra Pars Compacta
8%
Transcranial Direct Current Stimulation
100%
Transcranial Magnetic Stimulation
16%
Ventral Tegmental Area
8%
Voltage Gated Calcium Channel
33%
